Literature DB >> 17162623

Weight gain occurs after onset of bipolar illness in overweight bipolar patients.

Amy Shah1, Nicholas Shen, Rif S El-Mallakh.   

Abstract

BACKGROUND: Bipolar patients appear to have a risk of weight gain and obesity higher than the general population. This has traditionally been attributed to medication and disease variables, but there have not been any studies that have investigated this directly.
METHODS: We examined 32 consecutive bipolar subjects and 32 matched controls for weight, BMI, fat content, and historic weight at age 18.
RESULTS: Bipolar patients were heavier (193.1 +/- 55.6 vs. 165.6 +/- 37.8 lbs., P = 0.03), with greater BMI (30.3 +/- 8.8 vs. 24.3 +/- 4.0, P = 0.001), and higher fat content (33.3 +/- 9.9 vs. 19.1 +/- 9.9%, P < 0.0001) than psychiatrically well controls. A larger fraction of bipolar subjects were obese (BMI > 30, 50% vs. 9.7%, z = 3.88, P < 0.01). However, weight at age 18 was not statistically different (143.0 +/- 35.8 for bipolar subjects vs. 152.8 +/- 42.7 lbs., P = 0.3).
CONCLUSIONS: This is the first controlled study examining weight gain in bipolar illness and the first demonstration that premorbid weight is in the normal range for bipolar subjects. Subsequent weight gain is probably related to illness and treatment variables.

Entities:  

Mesh:

Year:  2006        PMID: 17162623     DOI: 10.1080/10401230600948423

Source DB:  PubMed          Journal:  Ann Clin Psychiatry        ISSN: 1040-1237            Impact factor:   1.567


  14 in total

1.  Effects of a multimodal lifestyle intervention on body mass index in patients with bipolar disorder: a randomized controlled trial.

Authors:  Kornelia Gillhoff; Jens Gaab; Luljeta Emini; Caroline Maroni; Joachim Tholuck; Waldemar Greil
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2010

2.  Manic/hypomanic symptom burden and cardiovascular mortality in bipolar disorder.

Authors:  Jess G Fiedorowicz; David A Solomon; Jean Endicott; Andrew C Leon; Chunshan Li; John P Rice; William H Coryell
Journal:  Psychosom Med       Date:  2009-06-26       Impact factor: 4.312

Review 3.  Cardiovascular morbidity and mortality in bipolar disorder.

Authors:  Miriam Weiner; Lois Warren; Jess G Fiedorowicz
Journal:  Ann Clin Psychiatry       Date:  2011-02       Impact factor: 1.567

4.  The association between mood and anxiety disorders with vascular diseases and risk factors in a nationally representative sample.

Authors:  Jess G Fiedorowicz; Jianping He; Kathleen R Merikangas
Journal:  J Psychosom Res       Date:  2010-09-18       Impact factor: 3.006

5.  The diagnosis and treatment of bipolar disorder: decision-making in primary care.

Authors:  Larry Culpepper
Journal:  Prim Care Companion CNS Disord       Date:  2014-06-19

Review 6.  Suicide in stroke survivors: epidemiology and prevention.

Authors:  Maurizio Pompili; Paola Venturini; Dorian A Lamis; Gloria Giordano; Gianluca Serafini; Martino Belvederi Murri; Mario Amore; Paolo Girardi
Journal:  Drugs Aging       Date:  2015-01       Impact factor: 3.923

Review 7.  Mania and mortality: why the excess cardiovascular risk in bipolar disorder?

Authors:  Dylan P Murray; Miriam Weiner; Maithri Prabhakar; Jess G Fiedorowicz
Journal:  Curr Psychiatry Rep       Date:  2009-12       Impact factor: 5.285

8.  Obesity and the three-year longitudinal course of bipolar disorder.

Authors:  Benjamin I Goldstein; Shang-Min Liu; Ayal Schaffer; Regina Sala; Carlos Blanco
Journal:  Bipolar Disord       Date:  2013-01-03       Impact factor: 6.744

Review 9.  Bipolar disorder and the metabolic syndrome: causal factors, psychiatric outcomes and economic burden.

Authors:  Andrea Fagiolini; K N Roy Chengappa; Isabella Soreca; Jane Chang
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

10.  Elevated prevalence of obesity, metabolic syndrome, and cardiovascular risk factors in bipolar disorder.

Authors:  Jess G Fiedorowicz; Narasimha M Palagummi; Valerie L Forman-Hoffman; Del D Miller; William G Haynes
Journal:  Ann Clin Psychiatry       Date:  2008 Jul-Sep       Impact factor: 1.567

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.